Literature DB >> 8545201

Correlates of osteopenia in patients with cystic fibrosis.

G S Bhudhikanok1, J Lim, R Marcus, A Harkins, R B Moss, L K Bachrach.   

Abstract

OBJECTIVE: As the expected survival improves for individuals with cystic fibrosis, these individuals face myriad medical complications. The goals of this study were to examine the prevalence of osteopenia in children and adults with cystic fibrosis and to elucidate the risk factors associated with deficits in bone mineral.
METHODOLOGY: We compared bone mineral levels in 49 patients (30 female and 19 male) ages 8 through 48 years with those of age- and sex-matched control subjects. Lumbar spine, femoral neck, and whole-body bone mineral were measured by dual-energy radiographic absorptiometry and expressed in terms of bone mineral content, areal bone density (BMD), and bone mineral apparent density (BMAD), which corrects for differences in bone size. Clinical variables were evaluated as potential correlates of bone mineral.
RESULTS: Patients with cystic fibrosis had significantly less bone mineral than did control subjects at all sites using all expressions of bone mass. Mean BMD z scores were -1.7 (lumbar spine), -1.9 (femoral neck), and -1.2 (whole body). BMAD z scores also were significantly low for age and gender. Twenty-six of the 49 patients (8 adolescents) had significant osteopenia according to their BMD z scores; 14 of the 45 patients (5 adolescents) with available BMAD z scores had significantly low values at one or more sites. Age, pubertal stage, body mass, caloric expenditure, illness severity, glucocorticoid therapy, and gonadal function predicted bone mineral status. Serum parathyroid hormone and calcium, carbohydrate intake, and weight-bearing activity had limited predictive value. Daily calcium intake and cystic fibrosis transmembrane regulator genotype did not predict bone mineral status.
CONCLUSIONS: Osteopenia is common at all ages in cystic fibrosis, suggesting that inadequate bone mineral accretion as well as increased bone loss contribute to the deficits in bone mineral observed. Several clinical factors seem to contribute to these deficits.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8545201

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

1.  Correlates of prepubertal bone mineral density in cystic fibrosis.

Authors:  R H Haslam; D J Borovnicar; D B Stroud; B J Strauss; J E Bines
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

2.  Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.

Authors:  Michael P Boyle; Michelle L Noschese; Sharon L Watts; Marsha E Davis; Shane E Stenner; Noah Lechtzin
Journal:  Am J Respir Crit Care Med       Date:  2005-04-28       Impact factor: 21.405

3.  The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis.

Authors:  Polyxeni Nicolaidou; Ilias Stavrinadis; Ioanna Loukou; Anna Papadopoulou; Helen Georgouli; Konstantinos Douros; Kostas N Priftis; Dimitrios Gourgiotis; Yiannis G Matsinos; Stavros Doudounakis
Journal:  Eur J Pediatr       Date:  2006-04-19       Impact factor: 3.183

4.  Bone mineral status in 134 patients with cystic fibrosis.

Authors:  E M Laursen; C Molgaard; K F Michaelsen; C Koch; J Müller
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

5.  Calcium acquisition rates do not support age-appropriate gains in total body bone mineral content in prepuberty and late puberty in girls with cystic fibrosis.

Authors:  K J Schulze; C Cutchins; B J Rosenstein; E L Germain-Lee; K O O'Brien
Journal:  Osteoporos Int       Date:  2006-02-28       Impact factor: 4.507

6.  Bone mineral and body composition alterations in paediatric cystic fibrosis patients.

Authors:  Philippe Reix; Gabriel Bellon; Pierre Braillon
Journal:  Pediatr Radiol       Date:  2009-12-03

7.  Vitamin d deficiency in cystic fibrosis.

Authors:  William B Hall; Amy A Sparks; Robert M Aris
Journal:  Int J Endocrinol       Date:  2010-01-28       Impact factor: 3.257

8.  A prospective study of change in bone mineral density over one year in adults with cystic fibrosis.

Authors:  C S Haworth; P L Selby; A W Horrocks; E B Mawer; J E Adams; A K Webb
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

9.  Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.

Authors:  C M Gordon; E Binello; M S LeBoff; M E Wohl; C J Rosen; A A Colin
Journal:  Osteoporos Int       Date:  2006-03-16       Impact factor: 4.507

10.  Nutrient status of adults with cystic fibrosis.

Authors:  Catherine M Gordon; Ellen J Anderson; Karen Herlyn; Jane L Hubbard; Angela Pizzo; Rondi Gelbard; Allen Lapey; Peter A Merkel
Journal:  J Am Diet Assoc       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.